Regulatory T cells in HIV infection: Who's suppressing what?

Current Infectious Disease Reports

Volumn 10, Issue 3, 2008, Pages 252-258

  Seddiki, Nabila ^a   Kelleher, Anthony D ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 2; IPILIMUMAB; MESSENGER RNA;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOLOGY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EFFECTOR CELL; GENE EXPRESSION REGULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MONOTHERAPY; NONHUMAN; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIROGENESIS; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

EID: 56349112846     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0041-8     Document Type: Review

References (51)

1. Miedema F: Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic Rev 1992, 3:173-193.
2. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
3. Gambineri E, Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003, 15:430-435.
4. Rouse BT, Sarangi PP, Suvas S: Regulatory T cells in virus infections. Immunol Rev 2006, 212:272-286.
5. Groux H, O'Garra A, Bigler M, et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
6. Walker MR, Kasprowicz DJ, Gersuk VH, et al.: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003, 112:1437-1443.
7. Tran DQ, Ramsey H, Shevach EM: Induction of FOXP3 expression in naive human CD4+FOXP3-T cells by T cell receptor stimulation is TGF{beta}-dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
8. von Boehmer H: Mechanisms of suppression by suppressor T cells. Nat Immunol 2005, 6:338-344.
9. Tang Q, Adams JY, Tooley AJ, et al.: Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006, 7:83-92.
10. Epple HJ, Loddenkemper C, Kunkel D, et al.: Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006, 108:3072-3078.
11. Kinter AL, Hennessey M, Bell A, et al.: CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004, 200:331-343.
12. Andersson J, Boasso A, Nilsson J, et al.: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005, 174:3143-3147.
13. Eggena MP, Barugahare B, Jones N, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005, 174:4407-4414.
14. Krathwohl MD, Schacker TW, Anderson JL: Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J Infect Dis 2006, 193:494-504.
15. Tsunemi S, Iwasaki T, Imado T, et al.: Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 2005, 19:879-886.
16. Lim A, Tan D, Price P, et al.: Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007, 21:1525-1534.
17. Montes M, Lewis DE, Sanchez C, et al.: Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006, 20:1669-1671.
18. Allan SE, Passerini L, Bacchetta R, et al.: The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005, 115:3276-3284.
19. Wang HY, Wang RF: Regulatory T cells and cancer. Curr Opin Immunol 2007, 19:217-223.
20. Owen CJ, Jennings CE, Imrie H, et al.: Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab 2003, 88:6034-6039.
21. Xu L, Kitani A, Fuss I, et al.: Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007, 178:6725-6729.
22. Kinter A, McNally J, Riggin L, et al.: Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A 2007, 104:3390-3395.
23. Liu W, Putnam AL, Xu-Yu Z, et al.: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711.
24. Seddiki N, Santner-Nanan B, Martinson J, et al.: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
25. Zaunders JJ, Ip S, Munier ML, et al.: Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol 2006, 80:10162-10172.
26. Seddiki N, Santner-Nanan B, Tangye SG, et al.: Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 2006, 107:2830-2838.
27. Douek DC, Betts MR, Hill BJ, et al.: Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001, 167:6663-6668.
28. Deaglio S, Dwyer KM, Gao W, et al.: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007, 204:1257-1265.
29. Douek D: HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 2007, 15:114-117.
30. Nilsson J, Boasso A, Velilla PA, et al.: HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006, 108:3808-3817.
31. Estes JD, Li Q, Reynolds MR, et al.: Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006, 193:703-712.
32. Boasso A, Vaccari M, Hryniewicz A, et al.: Regulatory T cell markers, indoleamine (2,3)-dioxygenase and virus levels in spleen and gut during progressive SIV infection. J Virol 2007, 81:11593-11603.
33. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al.: Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006, 116:2423-2433.
34. Chen W, Jin W, Hardegen N, et al.: Conversion of peripheral CD4+CD25- naïve T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
35. Sakaguchi S: Regulatory T cells: mediating compromises between host and parasite. Nat Immunol 2003, 4:10-11.
36. Younes SA, Yassine-Diab B, Dumont AR, et al.: HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003, 198:1909-1922.
37. Zaunders JJ, Dyer WB, Munier ML, et al.: CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells. J Virol 2006, 80:10151-10161.
38. Baker CA, Clark R, Ventura F, et al: Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 2007, 147:533-539.
39. Weiss L, Donkova-Petrini V, Caccavelli L, et al.: Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004, 104:3249-3256.
40. Oswald-Richter K, Grill SM, Shariat N, et al.: HIV infection of naturally occurring and genetically reprogrammed human regulatory T cells. PLoS Biol 2004, 2:e198.
41. Holmes D, Knudsen G, Mackey-Cushman S, et al.: FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem 2007, 282:15973-15980.
42. Grant C, Oh U, Fugo K, et al.: Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2006, 2:e33.
43. Aandahl EM, Michaelsson J, Moretto WJ, et al.: Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004, 78:2454-2459.
44. Apoil PA, Puissant B, Roubinet F, et al.: FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 2005, 39:381-385.
45. Hryniewicz A, Boasso A, Edghill-Smith Y, et al.: CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006, 108:3834-3842.
46. Raimondi G, Turner MS, Thomson AW, Morel PA: Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 2007, 27:61-95.
47. Sereti I, Imamichi H, Natarajan V, et al.: In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 2005, 115:1839-1847.
48. Glesby MJ, Bassett R, Alston-Smith B, et al.: Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis 2005, 191:686-693.
49. Chougnet CA, Shearer GM: Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop. AIDS Res Hum Retroviruses 2007, 23:945-952.
50. Kaufmann DE, Kavanagh DG, Pereyra F, et al.: CTLA-4 upregulation in HIV-specific CD4 T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007, In press.
51. Garber DA, Silvestri G, Barry AP, et al.: Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. J Clin Invest 2004, 113:836-845.